Filters: Keyword is Hepatitis C, Chronic [Clear All Filters]
"Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET." Journal of hepatology 62, no. 2 (2015): 286-93. Abstract
"Reply to Marcellin et al." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 59, no. 8 (2014): 1192-3.
"Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial." The Lancet infectious diseases 12, no. 9 (2012): 671-7. Abstract
"A comparison of treatment eligibility for hepatitis C virus in HCV-monoinfected versus HCV/HIV-coinfected persons in electronically retrieved cohort of HCV-infected veterans." AIDS research and human retroviruses 27, no. 9 (2011): 973-9. Abstract
"Hepatitis C treatment completion rates in routine clinical care." Liver international : official journal of the International Association for the Study of the Liver 30, no. 2 (2010): 240-50. Abstract
"The association between the receipt of lipid lowering therapy and HIV status among veterans who met NCEP/ATP III criteria for the receipt of lipid lowering medication." Journal of general internal medicine 24, no. 3 (2009): 334-40. Abstract
"HIV infection and the risk of diabetes mellitus." AIDS (London, England) 23, no. 10 (2009): 1227-34. Abstract
